Medicalgorithmics S.A.

Report Publication Announcement • Dec 17, 2025

Report Content Informationon the conclusion of a co-financing agreement with PARP byMedicalgorithmics S.A.

CurrentReport No.: 40/2025

Date:17.12.2025 r.

Legalbasis:Article17(1) of Regulation (EU) No 596/2014 of the European Parliament and ofthe Council (MAR) - inside information.

TheManagement Board of Medicalgorithmics S.A. with its registered office inWarsaw (the "Company") hereby announces that on 17 December2025, the Company, as the Beneficiary, and the Polish Agency forEnterprise Development ("PARP"; "Institution")entered into an Agreement for co-financing the implementation of theproject entitled "Kardiobeat.CT - an innovative diagnostic tool forautomatic detection of atherosclerotic plaques" (the "Project")(the "Agreement"). The Agreement was concluded under theEuropean Funds for Modern Economy Program, priority: I. Support forentrepreneurs, under the measure: SMART Path, under the call:FENG.01.01-IP.02-001/24 (the "Program"). The Companyannounced that PARP had selected the Company's application forco-financing in the amount of PLN 9,415,712.50 in current report No.17/2025 of 17 July 2025.

Thesubject matter of the concluded Agreement is the granting ofco-financing to the Company by the Institution for the implementation ofthe Project in accordance with the Agreement and the implementation ofthe Project by the Company with due diligence and the use ofco-financing in accordance with the Agreement.

Thetotal cost of the Project is PLN 19,072,879.00.

Thetotal amount of eligible expenditure is PLN 18,831,425.00.

Thetotal amount of co-financing is PLN 9,415,712.50, however, this amountmay be changed, in accordance with the rules set out in the Agreement.

Theperiod of eligibility of expenditure for the Project begins on 1 June2025 (the date of commencement of the Project) and ends on 31 December2028 (the date of completion of the Project).

TheCompany is obliged to achieve the objectives and indicators of theProject specified in the application for co-financing by achieving theobjectives and indicators of each of the modules included in theProject. The Project includes the following modules: R+D andInternationalization. The Company is obliged to implement the results ofR+D work no later than 5 years from the completion of the R+D module.In addition,the Company is obliged to maintain the durability of the Project for aperiod of 3 years from the completion of the Project, taking intoaccount the detailed conditions for the implementation of the modulesspecified in the appendix to the Agreement.

Thefunding is granted on the basis of the Regulation of the Minister ofFunds and Regional Policy of 7 November 2022 on the granting offinancial assistance by the Polish Agency for Enterprise Developmentunder the European Funds for Modern Economy Program 2021-2027 (Journalof Laws of 2022, item 2510, as amended). The Institution transfers thesubsidy on the basis of payment requests submitted within the deadlinesspecified in the payment schedule. The subsidy is paid after the Companyhas established and provided security for the proper performance of itsobligations under the Agreement, which the Company is required to dowithin 14 days of the date of conclusion of the Agreement.